Publications by authors named "Anna Morgando"

Article Synopsis
  • The study focused on creating a scoring system called the OCA response score (ORS) to predict how individuals with primary biliary cholangitis (PBC) will respond to the treatment using obeticholic acid (OCA).
  • Data were collected from two large cohorts in Italy to derive and validate the score, which includes various clinical factors both before and after six months of treatment.
  • The scoring system demonstrated good predictive ability for treatment response, which could help healthcare providers customize therapies for patients with PBC more effectively.
View Article and Find Full Text PDF

Objective: Primary biliary cholangitis (PBC) is a rare chronic autoimmune cholangiopathy, characterized by a variable course and response to treatment. We aimed to describe long-term outcomes of PBC patients referred to three academic centres in Northwest Italy.

Methods: This is an ambispective cohort study of PBC patients (retrospective component: diagnosis before 1 January 2019; prospective component: thereafter), including 302 patients: 101 (33%) followed up in Novara, 86 (28%) in Turin, 115 (38%) in Genoa.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the safety and effectiveness of obeticholic acid (OCA) in patients with primary biliary cholangitis (PBC) who have advanced cirrhosis.
  • Factors such as male sex, INR levels, Child-Pugh score, MELD score, and bilirubin levels were linked to non-response and serious adverse events (SAEs) in patients taking OCA.
  • The findings suggest that careful baseline evaluations, especially bilirubin levels above 1.4 mg/dl, are essential in determining which patients can safely benefit from OCA treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Obeticholic acid (OCA) is an effective second-line treatment for primary biliary cholangitis (PBC) patients who do not respond well to ursodeoxycholic acid.
  • A study involving 191 patients showed significant reductions in liver enzyme levels after 12 months of OCA treatment, though patients with cirrhosis had lower response rates and a higher discontinuation rate due to adverse effects.
  • Overall, the real-world effectiveness and safety of OCA align with earlier clinical trials, indicating potential benefits for certain patient subgroups, including those with overlap PBC-AIH.
View Article and Find Full Text PDF

The most commonly used regimens fail to eradicate () infection in 5⁻10% of patients. Those not cured with treatments based on amoxicillin, clarithromycin, nitroimidazoles, fluoroquinolones, bismuth or tetracycline have no other conventional options thereafter. In this prospective long-term monocentric study, patients who failed to eradicate following treatment with all conventional antibiotics were included.

View Article and Find Full Text PDF

Background: Primary biliary cholangitis (PBC) is an autoimmune cholestatic liver disease with unknown etiology. The prognosis of patients affected by PBC is heterogeneous, with a relevant improvement achieved after the introduction of ursodeoxycolic acid (UDCA). Since in the last years obeticholic acid (OCA) has been approved for the combined treatment of PBC, in patient non-responders to UDCA or as monotherapy in those intolerant to UDCA, we evaluated the response to UDCA in a cohort of patients with PBC managed in a specialistic setting.

View Article and Find Full Text PDF

This special article reports on two crucial issues discussed during a meeting. The first was the updated management of Helicobacter pylori (H. pylori) infection.

View Article and Find Full Text PDF

Background: There are few data on clinical relevance of adrenal dysfunction and its relationship with occult microbial DNA in noninfected haemodynamically stable cirrhotic patients with ascites.

Aims: The aim of this study was to evaluate prognostic role of adrenal dysfunction, microbial DNA, and their relationship.

Methods: Adrenal function was assessed in 93 consecutive patients following a corticotropin stimulation test.

View Article and Find Full Text PDF

A/H1N1/09 influenza is associated with a high risk of complications in patients with chronic diseases, but data on morbidity and mortality in patients with cirrhosis are limited. A cluster of A/H1N1/09 infection in 48 patients admitted to a Gastro-Hepatology Unit is reported. Nosocomial spread, clinical outcome, and viral characteristics of A/H1N1/09 strains from a study group of 48 inpatients (21 and 27 with and without cirrhosis, respectively) were compared with those from a control group of 44 outpatients with mild influenza-like illness and without cirrhosis.

View Article and Find Full Text PDF

Background: Paracentesis-induced circulatory dysfunction is a well-known complication of large volume paracentesis. Albumin infusion (8g of albumin/L of ascites removed) is effective in preventing it, but high costs and scant availability limit its use.

Aim: To compare standard vs half albumin doses.

View Article and Find Full Text PDF

Background: The potential role of digestive endoscopy as a mode for transmission of hepatitis C virus (HCV) is controversial.

Objective: To evaluate the role of digestive endoscopy in transmitting HCV by comparing the incidence of HCV infection in a cohort of patients undergoing endoscopy and in a cohort of blood donors.

Design: Prospective cohort study.

View Article and Find Full Text PDF

Duodenal mucosa-associated lymphoid tissue lymphoma is a rare neoplasm. We report a case of a 70-year-old man with non-Hodgkin's lymphoma located in the descending duodenum that was not associated with Helicobacter pylori infection of the stomach. A surgical resection due to obstruction of the bowel lumen above the ligament of Treitz was performed.

View Article and Find Full Text PDF